Abstract:Background and Aim: By Affymatrix SNP6 array screening for copy number variations in gastric cancer (GC), we identified the nuclear protein-coding gene C8orf76 (chromosome 8 open reading frame 76) to be preferentially amplified in primary gastric tumors.However, the role of C8orf76 in human cancer remains unknown.This study aimed to elucidate the biological function, molecular mechanism and clinical significance of C8orf76 in GC.Methods: C8orf76 copy number was quantified by TaqMan qPCR assays.C8orf76 expression was assessed by RT-qPCR and immunohistochemistry. Molecular networks were investigated by RNA sequencing and pathway luciferase reporter assays.Direct downstream genes were elucidated by chromatin immunoprecipitation (ChIP)-sequencing.ChIP-PCR, luciferase reporter and electrophoretic mobility shift assay (EMSA) were performed to detect the binding effect of C8orf76 on candidate DNA motifs.Results: C8orf76 copy number was significantly increased in GC tumors compared to adjacent non-tumor tissues ( P<0.01).Consistently, C8orf76 mRNA and protein were significantly up-regulated in GC tumors compared to adjacent non-tumor tissues (both P<0.001).C8orf76 mRNA expression was positively correlated with its copy number in GC (n=66, R=0.64, P<0.0001), which was validated in TCGA cohort (n=414, R=0.74, P<0.0001).C8orf76 copy gain was significantly associated with advanced TNM stage ( P<0.05).Copy gain and overexpression of C8orf76 were significantly associated with poor prognosis in GC patients (both P<0.05).C8orf76 overexpression in GC cell line (AGS) and normal gastric epithelial cell line (GES1) significantly increased cell viability and clonogenicity, promoted G1-S cell cycle transition, inhibited apoptosis, and enhanced cell migration/invasion abilities (all P<0.05).Conversely, C8orf76 knockdown in GC cells (BGC823 and MKN28) exhibited opposite effects.In addition, MAPK signaling was activated by C8orf76 as identified by RNA sequencing, confirmed by increased SRE reporter activity ( P<0.001) and activation of ERK/2 and p38.The lncRNA DUSP5P1 was identified to be a downstream effector of C8orf76 by ChIP-sequencing and RNA-sequencing.Direct binding of C8orf76 protein to the DNA motif 'AGGCTG' at the promoter region of DUSP5P1 was verified by ChIP-PCR, luciferase reporter assay and EMSA.Expression of DUSP5P1 was positively correlated with C8orf76 levels in GC cells with C8orf76 overexpression or knockdown.Moreover, knockdown of DUSP5P1 could abolish the effects of C8orf76 on cell growth and MAPK activation.Conclusions: C8orf76 is a novel oncogenic factor that is commonly overexpressed in GC due to copy number gain.The tumor promoting effect of C8orf76 in GC was mediated by activating MAPK signaling through directly inducing lncRNA DUSP5P1.C8orf76 copy number and expression serve as potential prognostic biomarkers for GC patients.

Identification of Genes with A Correlation Between Copy Number and Expression in Gastric Cancer

Identification of Significant Biomarkers and Pathways Associated with Gastric Carcinogenesis by Whole Genome-Wide Expression Profiling Analysis

Integration of DNA Copy Number Alterations and Transcriptional Expression Analysis in Human Gastric Cancer

Global Gene Expression and Functional Network Analysis of Gastric Cancer Identify Extended Pathway Maps and GPRC5A As a Potential Biomarker.

Identification Oftyrobpandc1qbas Two Novel Key Genes with Prognostic Value in Gastric Cancer by Network Analysis

Identification of Differentially Expressed Genes in the Gastric Cancer Patient by Laser Microdissection and Cdna Microarray

Combining Multi-Dimensional Data to Identify Key Genes and Pathways in Gastric Cancer

Screening for Amplification Genomic Loci and Genes Associated Prognosis in Gastric Cancer

Identification of Tumor Mutation Burden, Microsatellite Instability, and Somatic Copy Number Alteration Derived Nine Gene Signatures to Predict Clinical Outcomes in STAD.

Identification of LncRNA Prognostic Biomarkers Associated with Copy Number Variants in Gastric Cancer

Identification of Differentially Expressed Genes in Gastric Cancer by High Density Cdna Microarray.

[Chromosomal Alterations Analyzed by Comparative Genomic Hybridization in Primary Gastric Carcinoma].

Identification of Differentially-Expressed Genes in Intestinal Gastric Cancer by Microarray Analysis.

Identification and Validation of Key Genes of Differential Correlations in Gastric Cancer

Comparison of Chromosomal Aberrations Between Primary Tumors and Their Synchronous Lymph-Node Metastases in Intestinal-Type Gastric Carcinoma.

Clinical Significance of Chromosomal Integrity in Gastric Cancers.

Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray.

Su1241 - C8ORF76 Functions As a Novel Oncogene Via Directly Regulating Lncrna DUSP5P1 in Gastric Cancer

Identification of Potential Core Genes in Gastric Cancer Using Bioinformatics Analysis.

Identification of Key Genes with Differential Correlations in Lung Adenocarcinoma

[Analysis of Human Gastric Cancer by Transcriptome and Proteome Profiling].